Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

36
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
36
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

47
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
47
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

52
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
52
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

44
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
44
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

156
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
156
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

46
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
46

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Point-of-care ultrasound to evaluate volume status in congestive heart failure.

Journal of cardiovascular imaging·2026
Same author

Perceptions of Consent for Operative Vaginal Delivery: A Service Evaluation.

Joint Commission journal on quality and patient safety·2026
Same author

Non-Anticoagulated Fresh Whole Blood Syringe Transfusion as an Alternative for Military Hemorrhage Resuscitation in Austere Environments.

Military medicine·2026
Same author

2024 Update on Vascular Anesthesia.

Journal of cardiothoracic and vascular anesthesia·2025
Same author

Volatile Anesthetic Agents Are Preferred Over Total Intravenous Anesthesia in Cardiac Surgery Under Cardiopulmonary Bypass.

Journal of cardiothoracic and vascular anesthesia·2024
Same author

Reviewing past and present consent practices in unplanned obstetric interventions: an eye towards the future.

Journal of medical ethics·2024

Related Experiment Video

Updated: Sep 28, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.6K

Right Heart Failure Management: Focus on Mechanical Support Options.

Meena Bhatia1, Shawn Jia1, Alan Smeltz1

  • 1Department of Anesthesiology, University of North Carolina at Chapel Hill, Chapel Hill, NC.

Journal of Cardiothoracic and Vascular Anesthesia
|March 28, 2022
PubMed
Summary

Right heart failure (RHF) affects millions, with advanced cases challenging to manage. This review explores RHF pathophysiology, medical treatments, and advanced mechanical therapies to guide clinical decisions.

Keywords:
Impella RPProtekDuoRight heart failureTandemHeartventricular assist devices

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.8K
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.0K

Related Experiment Videos

Last Updated: Sep 28, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.6K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.8K
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.0K

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Pulmonary Hypertension

Background:

  • Right heart failure (RHF) is a significant clinical problem in millions of American adults, characterized by high morbidity and mortality.
  • RHF arises from diverse etiologies and complex pathophysiological mechanisms, often leading to a progressive decline.
  • Management of advanced RHF, especially in patients refractory to medical therapies, presents considerable challenges.

Purpose of the Study:

  • To review the pathophysiology and current medical management strategies for right heart failure.
  • To provide a comprehensive overview of available advanced mechanical therapies for RHF.
  • To inform clinical decision-making for patients with advanced or refractory right heart failure.

Main Methods:

  • Literature review focusing on the pathophysiology of RHF.
  • Analysis of medical management approaches for RHF.
  • Evaluation of current mechanical assist devices for RHF, including extracorporeal oxygenation and ventricular assist devices.

Main Results:

  • RHF encompasses a wide range of causes and progressive mechanisms.
  • Medical management of RHF involves optimizing volume status, hemodynamics, and rhythm control.
  • Advanced mechanical therapies, such as V-A ECMO and RVADs (surgical and percutaneous), offer options for refractory RHF.

Conclusions:

  • Understanding RHF pathophysiology is crucial for effective management.
  • Mechanical therapies provide vital support for select RHF patients unresponsive to medical treatment.
  • The choice of mechanical therapy depends on individual patient context, with distinct advantages and limitations.